References
- Skiest DJ. Cytomegalovirus retinitis in the era of highly active retroviral therapy (HAART). Am J Med Sci. 1999;317:318–335.
- Holland GN. New strategies for the management of AIDS-related CMV retinitis in the era of potent antiretroviral therapy. Ocul Immunol Inflamm. 1999;7:179–188.
- Akler ME, Johnson DW, Burman WJ, Johnson SC. Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomelagovirus retinitis. Ophthalmology. 1998;105:651–657.
- Ambati J, Wynne KB, Angerame MC, Robinson MR. Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol. 1999;83:1153—1158.
- Bainbridge JVV, Raina J, Shah SM, Ainsworth J, Pinching AJ. Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS. Eye. 1999;13(Pt 3a):353–356.
- Berenguer J, Mattolas J. Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group. Clin Infect Dis. 2000;30: 182–184.
- Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, Leonard RE. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol. 1997;115: 733–737.
- Cochereau I, Doan S, Diraison MC, Mousalatti H, Guvenisik N, Ren L, Hoang-Xuan T. Uveitis in patients treated with intravenous cidofovir. Ocul Immunol Inflamm. 1999;7: 223–229.
- Accorinti M, Ciapparoni V, Pirragli MP, Pivetti-Pezzi P. Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis. Ocul Immunol Inflamm. 2001;9:211–217.
- Lin AP, Holland GN, Engstrom RE. Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment. Retina. 1999;19:75–76.
- Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D, Bergeron-Lynn G, DeClercq E, Keefe K, Freeman WR. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Exp Eye Res. 1997;64:795–806.
- Velasco M, Luchsinger A. Dopamine: pharmacologic and therapeutic aspects. Am J Ther. 1998;5:37–43.
- McLaren JW, Bachman LA, Brubaker RE Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry. J Ocul Pharmacol Ther. 1999;15: 107–116.
- Virno M, Traverniti L, De Gregorio F, Sedran L, Longo E Increase in aqueous humor production following Di receptors activation by means of ibopamine. Int Ophthalmol. 1996–97;20: 141—I46.
- De Gregorio F, Pecori Giraldi J, Pannarale L, Saccucci S, Virno M. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test. Int Ophthalmol. 1996-97;20: 151–155.
- Virno M, De Gregorio F, Pannarale L, Arrico L. Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony. Int Ophthalmol. 1996–97;20:147–151.